Clinical outcomes of sofosbuvir/velpatasvir in hepatitis C virus-infected patients with end-stage renal disease on maintenance hemodialysis
Objective To evaluate the safety and efficacy of 12-week sofosbuvir/velpatasvir (SOF/VEL) in chronic hepatitis C (CHC) patients with end-stage renal disease (ESRD) on maintenance hemodialysis (MHD) in a real-world setting. Methods From October 10, 2020 to January 28, 2021, 18 CHC patients received f...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Chinês |
| Foilsithe / Cruthaithe: |
Editorial Department of Journal of Clinical Nephrology
2023-10-01
|
| Sraith: | Linchuang shenzangbing zazhi |
| Ábhair: | |
| Rochtain ar líne: | http://www.lcszb.com/cn/article/doi/10.3969/j.issn.1671-2390.2023.10.008 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|